GSK executive sells 38,000 ordinary shares

GSK plc reported that Regis Simard, President, Global Supply Chain, carried out a market transaction in the company’s shares.

Rhea-AI Filing Summary

GSK plc reported that Regis Simard, President, Global Supply Chain, carried out a market transaction in the company’s shares. Simard sold 38,000 Ordinary Shares of 31 ¼ pence each at a price of £20.3800 per share.

The sale took place on 29 July 2026 on the London Stock Exchange (XLON). The disclosure identifies Simard as a PDMR (person discharging managerial responsibilities) and classifies this as an initial notification of the transaction.

Filing Explained

GSK’s Form 6-K, an interim report for material information published by a foreign private issuer, records Regis Simard’s sale of 38,000 ordinary shares on July 29, 2026; the filing does not disclose a Rule 10b5-1 trading plan for the sale.

Key Figures

Shares sold: 38,000 shares Sale price: £20.3800 per share Nominal value: 31 ¼ pence each +1 more

4 metrics

Shares sold 38,000 shares Sale of GSK Ordinary Shares by Regis Simard

Sale price £20.3800 per share Price for the 38,000 Ordinary Shares sold

Nominal value 31 ¼ pence each Nominal value of GSK Ordinary Shares

Transaction date 2026-07-29 Date of the share sale on London Stock Exchange

Key Terms

PDMR, Ordinary Shares, ISIN, London Stock Exchange (XLON)

4 terms

PDMR financial

"Details of PDMR/person closely associated with them ('PCA')"

A PDMR (person discharging managerial responsibilities) is an individual who can shape a company’s strategy or finances—typically senior executives, board members, or close advisors with decision-making authority. Investors care because PDMRs often hold material, non‑public information and their buying or selling of shares must be reported; monitoring those disclosures is like watching a ship’s captain to read the likely course and spot possible insider risk.

Ordinary Shares financial

"Description of the financial instrument | Ordinary shares of 31 ¼ pence each"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

ISIN financial

"ISIN: GB00BN7SWP63"

A 12-character International Securities Identification Number (ISIN) is a unique code that acts like a passport for a specific stock, bond or other tradable security so it can be identified worldwide. Investors and systems use it to ensure they are buying, selling and tracking the exact same instrument across exchanges and data feeds, which prevents costly mix-ups and makes portfolio reporting, settlement and regulatory checks simpler and more reliable.

London Stock Exchange (XLON) financial

"Place of the transaction | London Stock Exchange (XLON)"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider share transaction did GSK (GSK) disclose in this report?

GSK disclosed that PDMR Regis Simard sold 38,000 Ordinary Shares. The shares, each with a nominal value of 31 ¼ pence, were sold on the London Stock Exchange as a single transaction reported as an initial notification.

Who is Regis Simard in relation to GSK (GSK)?

Regis Simard is identified as President, Global Supply Chain at GSK and is treated as a PDMR. As a senior executive, transactions in GSK shares by Simard are subject to disclosure requirements and reported through regulatory announcements.

How many GSK (GSK) shares were sold and at what price?

Regis Simard sold 38,000 GSK Ordinary Shares at a price of £20.3800 per share. The filing describes this as a single aggregated transaction, with no separate breakdown of volumes or prices beyond this disclosed figure.

When and where did the GSK (GSK) share sale by Regis Simard occur?

The transaction took place on 29 July 2026 on the London Stock Exchange (XLON). The report specifies London Stock Exchange as the trading venue for this sale of GSK Ordinary Shares by the senior executive.

What type of GSK (GSK) security did Regis Simard sell?

The transaction involved Ordinary Shares of 31 ¼ pence each in GSK. The filing identifies them as Ordinary Shares with ISIN GB00BN7SWP63, representing the company’s standard equity listed on the London Stock Exchange.

Is this GSK (GSK) transaction filing an initial notification or an amendment?

The filing classifies the disclosure as an initial notification of the transaction by Regis Simard. It is not marked as an amendment and therefore represents the first regulatory report of this particular share sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 12:26 PM Accepted by SEC EDGAR 07/30/2026 - 12:25 PM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of July 2026

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Regis Simard
b)	Position/status	President, Global Supply Chain
c)	Initial notification/amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GSK plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 31 ¼ pence each ('Ordinary Shares') ISIN: GB00BN7SWP63
b)	Nature of the transaction	Sale of 38,000 Ordinary Shares
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£20.3800	38,000
		d)	Aggregated information	N/A (single transaction)
Aggregated volume Price
e)	Date of the transaction	2026-07-29
f)	Place of the transaction	London Stock Exchange (XLON)

About GSK

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.

Registered in England & Wales:

No. 3888792

Registered Office:

79 New Oxford Street

London

WC1A 1DG

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

GSK plc

(Registrant)

Date: July 30, 2026

By:/s/ VICTORIA WHYTE

--------------------------

Victoria Whyte

Authorised Signatory for and on

behalf of GSK plc